ASX Announcements
Accent Group (ASX: AX1) – Takeover Panel Declines Proceedings Against AX1
The Takeovers Panel has declined to conduct proceedings on an application from Frasers Group concerning Accent Group Limited's disclosure in its...
Chalice Mining (ASX: CHN) – Q2 2026 Quarterly Activities Report
Chalice Mining Limited is advancing its flagship Gonneville palladium-nickel-copper project through critical de-risking phases ahead of a pilot...
MAAS Group Holdings (ASX: MGH) – Heidelberg Acquisition of MGH Businesses Approved
The ACCC has approved Heidelberg Materials Australia Holdings' acquisition of Maas Group Holdings' construction materials business, clearing a major...
Origin Energy (ASX: ORG) – Origin Energy Files Q1 2026 Report
Origin Energy delivered a strong financial year to 30 June 2026, with its Australia Pacific LNG operations producing 668 PJ and generating fully...
Scalare Partners Holdings (ASX: SCP) – Files Q3 Quarterly Activities Report
Scalare Partners (ASX: SCP) has completed its acquisition of Fishburners, one of Australia's most established startup communities, marking a...
Fortescue (ASX: FMG) – Fortescue Files June 2026 Quarterly Production Report
Fortescue Metals Group has delivered record annual iron ore shipments for FY26, reaching 201.3 million tonnes, with Q4 alone contributing 52.7...
Omni Bridgeway (ASX: OBL) – Investment Portfolio Report H1 2026
Omni Bridgeway Limited recorded record cash investment proceeds of A$350.5 million in the year ended 30 June 2026, capping 12 months of disciplined...
Monadelphous Group (ASX: MND) – Kerman secures Rio Tinto design and construction contract
Monadelphous Group Limited has secured a contract valued at approximately $165 million for its wholly owned subsidiary Kerman Contracting to design...
BetaShares Australian High Interest Cash ETF (ASX: AAA) – BetaShares AAA ETF Distribution Announcement
Betashares Capital Ltd has announced estimated distributions for two of its high-interest cash ETFs for the period ending 30 July 2026. The...
Mesoblast (ASX: MSB) – Q10 Quarterly Activities and Cash Flow Report
Mesoblast Limited has demonstrated meaningful commercial momentum with Ryoncil, its flagship cellular medicine, delivering US$115 million in net...